Health conditions and diseases starting with H Find trusted details on symptoms causes and treatments to take charge of your health with confidence
Hereditary Factor X Deficiency Disease is a rare genetic disorder characterized by impaired blood clotting due to insufficient or malfunctioning Factor X protein. This condition is classified as a bleeding disorder and is inherited in an autosomal recessive manner. What is Factor X? Factor X, also known as Stuart-Prower factor, is a critical coagulation protein
Hereditary Factor VII (FVII) deficiency is a rare genetic disorder characterized by insufficient levels or dysfunction of coagulation factor VII, a crucial protein involved in blood clotting. This condition can lead to excessive bleeding or prolonged bleeding episodes. Understanding Factor VII and Its Role in Blood Clotting Factor VII is a vitamin K-dependent protein produced
Hereditary coproporphyria (HCP) is a rare genetic disorder characterized by a deficiency in the enzyme coproporphyrinogen oxidase (CPOX), which is crucial in the heme biosynthesis pathway. This condition is classified as an acute hepatic porphyria, manifesting with intermittent neurovisceral attacks. Causes of Hereditary Coproporphyria HCP is caused by mutations in the CPOX gene. This gene
Hereditary Angioedema (HAE) is a rare genetic disorder that causes recurrent episodes of severe swelling in various parts of the body. This condition can significantly impact the quality of life and may become life-threatening without proper management. What is Hereditary Angioedema (HAE)? Hereditary Angioedema is an autosomal dominant disorder characterized by a deficiency or dysfunction
HER2-positive gastric adenocarcinoma is a subtype of stomach cancer characterized by the overexpression of the HER2 (human epidermal growth factor receptor 2) protein. This aggressive form of gastric cancer requires targeted therapies for optimal treatment outcomes. Understanding its diagnosis, treatment options, and prognosis is crucial for improving patient care. Understanding HER2 and Its Role in
HER2 positive colorectal cancer is a rare but aggressive subtype of colorectal cancer characterized by an overexpression of the HER2 gene. This condition affects a small percentage of patients but poses significant treatment challenges. Understanding its biology, diagnosis, and treatment options is crucial for improving outcomes. What Is HER2 Positive Colorectal Cancer? HER2 (human epidermal
HER2 positive carcinoma of the breast is an aggressive subtype of breast cancer characterized by the overexpression of the human epidermal growth factor receptor 2 (HER2) protein. This condition requires specific treatment strategies due to its unique molecular profile and increased proliferation rates. Understanding HER2 Positive Breast Cancer HER2 positive breast cancer accounts for approximately
HER2 positive biliary tract malignancy is a rare but aggressive form of cancer that affects the bile ducts, gallbladder, and ampulla of Vater. Understanding its molecular profile, diagnosis, and treatment options is crucial for improved patient outcomes. Understanding HER2 Positive Biliary Tract Cancer HER2 (Human Epidermal Growth Factor Receptor 2) overexpression is found in a
HER2-positive adenocarcinoma of the gastroesophageal junction (GEJ) is a rare yet aggressive malignancy that requires targeted treatment strategies. This condition is characterized by the overexpression of the human epidermal growth factor receptor 2 (HER2) protein, which promotes tumor cell proliferation. Understanding HER2 in Gastroesophageal Junction Cancer HER2 is a transmembrane receptor involved in cell growth
HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma is a challenging form of cancer with distinct characteristics that require specialized treatment approaches. Understanding its pathology, diagnosis, and treatment strategies is crucial for improving patient outcomes. Understanding HER2-Negative Gastric and GEJ Adenocarcinoma HER2-negative gastric and GEJ adenocarcinoma refers to cancers that lack the overexpression of the HER2